Washington University School of Medicine
St Louis, Missouri, 63110, United States
NCT Number: NCT03923699
Medical errors account for thousands of potentially preventable deaths each year. With the annual increase of surgical cases there is a need for research into the potential utility of a telemedicine-based control center for the operating room to assess risk, diagnose negative patient trajectories, implement evidence-based practices, and improve outcomes.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
St Louis, Missouri, 63110, United States
This will be a single center, randomized, controlled, phase 3 pragmatic clinical trial. Forty-eight operating rooms will be randomized daily to receive support from the ACT or not. All adults (eighteen years and older) undergoing surgical procedures in these operating rooms will be included and followed until 30-days after their surgery. Clinicians in operating rooms randomized to 'intervention' will receive decision support from clinicians in the ACT. In operating rooms not randomized to receive decision support from the ACT, the current standard of anesthesia care will be delivered. The intention-to-treat principle will be followed for all analyses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Real time data will be monitored through the AlertWatch® system as well as the patient's EHR.
Time frame: 30 days post-op
This will include death of any cause occurring in or out of the hospital, within 30 days of the index surgery.
Time frame: 7 days post-op
Defined as an acute change in consciousness or cognition. It has a fluctuating course, and is characterized by inattention, disorganized thinking and altered level of consciousness. The institution has trained the nursing staff on our surgical intensive care units to assess all patients for postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) instrument.
Time frame: 30 days post-op
Defined as mechanical ventilation for greater than 24 hours after surgery, or unplanned postoperative re-intubation and mechanical ventilation within 30 days of surgery.
Time frame: 7 days post-op
Diagnosed when any of the following three criteria are met: (i) an increase in serum creatinine by 50% compared with preoperative within 7 days, (ii) any increase in serum creatinine > 0.3 mg/dL in 48 hours, or (iii) oliguria (urine output <0.5 mL/kg/hr for 6-12 hours).
Time frame: 1 day
Percentage of patients with Temperature ≥ 36°C at end of surgery.
Time frame: 1 day
Percentage of patients with antibiotic redosing compliant with guidelines developed by the institutional pharmacy and therapeutics committee.
Time frame: 1 day
Percentage time during surgery with mean arterial pressure ≥ 60 mmHg
Time frame: 1 day
Percentage time during surgery with low PIP (peak inspiratory pressure)
Time frame: 1 day
Percentage of patients with blood glucose ≥ 200 mg/dL at end of surgery.
Time frame: 1 day
Percentage of patients without ≥ 15 consecutive min of anesthetic concentration ≤ 0.3 MAC during anesthetic maintenance period.
Time frame: 1 day
Percentage of patients with efficient fresh gas flow for ≥90% of the anesthetic maintenance period.
Washington University School of Medicine
Other
Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety - Randomized Pragmatic Trial
Acronym: TECTONICS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06770738
Anesthesia, Cardiac Disease
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05061407
Developing Countries, Hospital Mortality
Durban, KwaZuluNatal, South Africa
View Trial DetailsNCT03740438
Blood Loss, Surgical, Hemorrhage
Barcelona, Spain
View Trial DetailsNCT03695159
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Dallas, Texas, United States
View Trial Details